Antibodies can now be re-engineered to work inside cells, not just on their surface, using AI-guided redesign of their binding fragments so they remain stable in the intracellular environment and can directly bind disease-driving proteins such as…
Continue Reading
News Source: www.forbes.com

Leave a Reply